Diagnosis of Inflammatory Bowel Disease-Asian Perspectives: the Results of a Multinational Web-based Survey in the 8th Asian Organization for Crohn's and Colitis Meeting

Overview

Journal Intest Res

Date 2023 Aug 3

PMID 37533264

Authors

Han Hee Lee

Jae Jun Park

Bo-In Lee

Ida Hilmi

Jose Sollano

Zhi Hua Ran

Affiliations

Soon will be listed here.

Abstract

Background/aims: Inflammatory bowel disease (IBD) is no longer a rare disease in Asia, thus it needs to prepare recommendations relevant to Asian patients. This study aimed to identify disparities in the process of the diagnosis of IBD in Asian countries/regions.

Methods: In line with the 2020 Asian Organization for Crohn's and Colitis annual meeting, a multinational web-based survey about Asian physicians' perspectives on IBD was conducted.

Results: A total of 384 Asian physicians (99 in China, 93 in Japan, 110 in Korea, and 82 in other Asian countries/regions) treating IBD patients from 24 countries/regions responded to the survey. Most respondents were gastroenterologists working in an academic teaching hospital. About half of them had more than 10 years of clinical experience in caring for patients with IBD. The European Crohn's Colitis Organisation guideline was used most commonly for the diagnosis of IBD except for Japanese physicians who preferred their own national guideline. The Mayo score and Crohn's Disease Activity Index were the most commonly used activity scoring systems for ulcerative colitis and Crohn's disease, respectively. Endoscopy, not surprisingly, was the main investigation in assessing the extent and activity of IBD. On the other hand, there were disparities across countries/regions with regard to the favored modalities of small bowel and perianal evaluation of Crohn's disease, as well as the use of serologic markers.

Conclusions: Results of the present survey revealed practical behaviors of Asian physicians in the diagnosis of IBD. Investigating the reasons for different diagnostic approaches among countries/regions might help us develop Asian guidelines further.

References

Schoepfer A, Beglinger C, Straumann A, Trummler M, Renzulli P, Seibold F . Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes. Inflamm Bowel Dis. 2009; 15(12):1851-8. DOI: 10.1002/ibd.20986. View

Gomollon F, Dignass A, Annese V, Tilg H, Van Assche G, Lindsay J . 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management. J Crohns Colitis. 2016; 11(1):3-25. DOI: 10.1093/ecco-jcc/jjw168. View

Ng W, Wong S, Ng S . Changing epidemiological trends of inflammatory bowel disease in Asia. Intest Res. 2016; 14(2):111-9. PMC: 4863044. DOI: 10.5217/ir.2016.14.2.111. View

Ran Z, Wu K, Matsuoka K, Jeen Y, Wei S, Ahuja V . Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia. J Gastroenterol Hepatol. 2020; 36(3):637-645. DOI: 10.1111/jgh.15185. View

Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M . Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. J Crohns Colitis. 2017; 11(6):649-670. DOI: 10.1093/ecco-jcc/jjx008. View

Ng S, Tang W, Ching J, Wong M, Chow C, Hui A . Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology. 2013; 145(1):158-165.e2. DOI: 10.1053/j.gastro.2013.04.007. View

Kim H, Hann H, Hong S, Kim K, Ahn I, Song J . Incidence and natural course of inflammatory bowel disease in Korea, 2006-2012: a nationwide population-based study. Inflamm Bowel Dis. 2015; 21(3):623-30. DOI: 10.1097/MIB.0000000000000313. View

TRUELOVE S, Witts L . Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955; 2(4947):1041-8. PMC: 1981500. DOI: 10.1136/bmj.2.4947.1041. View

Singh P, Ananthakrishnan A, Ahuja V . Pivot to Asia: inflammatory bowel disease burden. Intest Res. 2017; 15(1):138-141. PMC: 5323305. DOI: 10.5217/ir.2017.15.1.138. View

10.

Ng S, Shi H, Hamidi N, Underwood F, Tang W, Benchimol E . Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017; 390(10114):2769-2778. DOI: 10.1016/S0140-6736(17)32448-0. View

11.

Lichtenstein G, Loftus E, Isaacs K, Regueiro M, Gerson L, Sands B . ACG Clinical Guideline: Management of Crohn's Disease in Adults. Am J Gastroenterol. 2018; 113(4):481-517. DOI: 10.1038/ajg.2018.27. View

12.

Ng S . Emerging leadership lecture: Inflammatory bowel disease in Asia: emergence of a "Western" disease. J Gastroenterol Hepatol. 2014; 30(3):440-5. DOI: 10.1111/jgh.12859. View

13.

Ghoshal U, Ghoshal U, Singh H, Tiwari S . Anti-Saccharomyces cerevisiae antibody is not useful to differentiate between Crohn's disease and intestinal tuberculosis in India. J Postgrad Med. 2007; 53(3):166-70. DOI: 10.4103/0022-3859.33857. View

14.

Lawrance I, Murray K, Hall A, Sung J, Leong R . A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients. Am J Gastroenterol. 2004; 99(11):2186-94. DOI: 10.1111/j.1572-0241.2004.40486.x. View

15.

Travis S, Schnell D, Krzeski P, Abreu M, Altman D, Colombel J . Reliability and initial validation of the ulcerative colitis endoscopic index of severity. Gastroenterology. 2013; 145(5):987-95. DOI: 10.1053/j.gastro.2013.07.024. View

16.

Kim E, Chen M, Lee J, Lee C, Kim Y . Diagnosis of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2(nd) Asian Organization for Crohn's and Colitis (AOCC) meeting in Seoul. Intest Res. 2016; 14(3):224-30. PMC: 4945526. DOI: 10.5217/ir.2016.14.3.224. View

17.

Saigusa K, Matsuoka K, Sugimoto S, Arai M, Kiyohara H, Takeshita K . Ulcerative colitis endoscopic index of severity is associated with long-term prognosis in ulcerative colitis patients treated with infliximab. Dig Endosc. 2016; 28(6):665-70. DOI: 10.1111/den.12655. View

18.

Ng S, Bernstein C, Vatn M, Lakatos P, Loftus Jr E, Tysk C . Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013; 62(4):630-49. DOI: 10.1136/gutjnl-2012-303661. View

19.

von Roon A, Karamountzos L, Purkayastha S, Reese G, Darzi A, Teare J . Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy. Am J Gastroenterol. 2007; 102(4):803-13. DOI: 10.1111/j.1572-0241.2007.01126.x. View

20.

Ng S, Kaplan G, Tang W, Banerjee R, Adigopula B, Underwood F . Population Density and Risk of Inflammatory Bowel Disease: A Prospective Population-Based Study in 13 Countries or Regions in Asia-Pacific. Am J Gastroenterol. 2018; 114(1):107-115. DOI: 10.1038/s41395-018-0233-2. View